Skip to main content
Clinical Trials/NCT02976805
NCT02976805CompletedPhase 3

A Multi-centre Endoscopist Blinded Randomized Clinical Trial to Compare Two Bowel Preparations After a Colonoscopy With Inadequate Bowel Preparation

Lawson Health Research Institute4 sites in 1 country196 target enrollmentStarted: February 13, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
196
Locations
4
Primary Endpoint
Adequate bowel preparation

Study Overview

Brief Summary

This is a multi-centre randomized clinical trial comparing the efficacy of two different bowel preparation regimens for patients who have already failed a bowel preparation for colonoscopy.

Detailed Description

PURPOSE

The purpose of this multi-centre randomized clinical trial is to compare two bowel preparation regimens for patients who fail to cleanse their colon during their index colonoscopy. Although many clinical trials already exist examining the optimal bowel preparation for colonoscopy in general, surprisingly none address patients who failed bowel preparation in the past. Failure to achieve bowel preparation is a result of complex factors, including underlying colonic dysmotility, co-morbidities, and concurrent medication usage and is rarely the result of patient non-compliance.(1) Given the frequency of inadequate bowel preparation, its negative impact on colonoscopy quality, the increased risk for an adverse event, and the need to repeat the procedure, an important public health need exists to address this question urgently.(1) This study will use many of the same methodology and investigators as an ongoing Canadian multicenter study titled, "The Bowel CLEAnsing: a National initiative ( B-CLEAN) " but on a smaller scale to answer this question.

BACKGROUND

Adequate bowel preparation is a prerequisite for high quality colonoscopy and is needed to maximize visualization of the colonic mucosa.(1-4) Unfortunately, inadequate bowel preparation is common and reported to occur in 4% to 17% of cases.(5-12) Procedures with poor preparation are more likely to be incomplete, have an adverse event, and are less likely to detect polyps.(1, 9, 13) Repeat colonoscopies within one year have shown a 36% miss rate for advanced adenomas in these patients.(12) Recognizing the importance of high quality colonoscopy, Cancer Care Ontario and other provincial health authorities now track adequacy rates for bowel preparation.

In cases of poor bowel preparation, the colonoscopy must be repeated, exposing patients to another invasive procedure and adding additional costs to the healthcare system. Although health economic data regarding colonoscopy utilization in Canada is sparse, an illustrative example from the United States is possible. Assuming 14.2 million screening colonoscopies are performed annually in the United States (14) of which 5% have inadequate bowel preparation (6, 8), a total of 710,000 colonoscopies have to be repeated at a cost of $763 million dollars, based on a per case cost of $1,075.(15) This is likely an underestimation of the true cost due to exclusion of non-screening colonoscopies in the calculation and the use of a low colonoscopy cost estimate based on the Nationwide Colonoscopy Program for the Uninsured.(15)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Anyone undergoing a repeat colonoscopy due to failed bowel preparation at index colonoscopy. Failure is defined as preparation quality inadequate to detect lesions > 5 mm after washing and requiring a shortened colonoscopy interval as a result.
  • Age > 18 years
  • Outpatient colonoscopy
  • Indication for full colonoscopy

Exclusion Criteria

  • Subject refusal
  • Able to comprehend the trial
  • Index colonoscopy performed as an inpatient
  • Pregnancy or breastfeeding
  • Allergies to the employed bowel preparations
  • Any colonic surgery
  • History of ischemic colitis
  • Congestive heart failure
  • Chronic renal failure
  • Severe electrolyte imbalance
  • Non-adherence to index bowel preparation defined as failure to follow diet instructions and/or consume the entire volume of bowel preparation medication as prescribed for any reason (ex. eating a normal diet on the day of colonoscopy, PEG intolerance, etc...)
  • Use of bowel preparation in an off-label manner for the index colonoscopy.
  • Inability to follow verbal and written instructions in English or French.
  • Ileus, gastric outlet obstruction, gastrointestinal obstruction, bowel preforation
  • Toxic coitis or toxic megacolon
  • Acute surgical abdomen including appendicitis
  • Gastroenteritis and acute diverticulitis

Arms & Interventions

Regimen A

Experimental

4L PegLyte + 15 mg bisacodyl

Intervention: 4L PegLyte + 15 mg bisacodyl (Drug)

Regimen B

Experimental

6L PegLyte + 15 mg bisacodyl

Intervention: 6L PegLyte + 15 mg bisacodyl (Drug)

Outcomes

Primary Outcomes

Adequate bowel preparation

Time Frame: Once after colonoscopy

BBPS total score ≥6 and/or all segment scores ≥2.

Secondary Outcomes

  • Mean BBPS total score(Once after colonoscopy)
  • Bowel preparation was adequate after washing to visualize lesions > 5 mm of importance to the procedure and there is no need to shorten the interval of the next colonoscopy(Once after colonoscopy)
  • Validated patient tolerability questionnaire for bowel preparation score(Once after colonoscopy)
  • Bowel preparation related adverse event(After colonoscopy and 14 days after colonoscopy)
  • Right sided BBPS sub-score(Up to 4 weeks after colonoscopy)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials